Asthma and proinflammatory conditions: A population-based retrospective matched cohort study

Mayo Clinic Proceedings

Volumn 87, Issue 10, 2012, Pages 953-960

  Yun, Hyun D ^a   Knoebel, Erin ^b   Fenta, Yilma ^b   Gabriel, Sherine E ^b   Leibson, Cynthia L ^b   Loftus Jr , Edward V ^b   Roger, Veronique ^b   Yawn, Barbara P ^c   Li, Bill ^b   Juhn, Young J ^b  

^a HARBOR HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

^c OLMSTED MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CELL POLARITY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HELPER CELL; HUMAN; INCIDENCE; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRESCHOOL CHILD; REGULATORY MECHANISM; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; UNITED STATES; COMORBIDITY; CORONARY ARTERY DISEASE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; ADULT; AGE OF ONSET; ARTHRITIS, RHEUMATOID; ASTHMA; CHILD; COMORBIDITY; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; MINNESOTA; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84871863153     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2012.05.020     Document Type: Article

References (49)

1. Lethbridge-Cejku M, Vickerie J. Summary of Health Statistics for US Adults: National Health Interview Survey, 2003. Hyattsville, MD: National Center for Health Statistics; 2005.
2. Centers for Disease Control and Prevention (CDC). Forecasted state-specific estimates of self-reported asthma prevalence - United States, 1998. MMWR Morb Mortal Wkly Rep. 1998;47(47):1022-1025.
3. World Health Organization. Fact sheet for asthma No. 307. http://www.who.int/mediacentre/factsheets/fs307/en/index. html. Accessed October 26, 2006.
4. Anandan C, Nurmatov U, van Schayck OCP, Sheikh A. Is the prevalence of asthma declining? systematic review of epidemiological studies. Allergy. 2010;65(2):152-167.
5. Centers for Disease Control and Prevention (CDC). Vital signs: asthma prevalence, disease characteristics, and self-management education - United States, 2001-2009. MMWR Morb Mortal Wkly Rep. 2011;60(17):547-552.
6. Barnett SB, Nurmagambetov TA. Costs of asthma in the United States:2002-2007. J Allergy Clin Immunol. 2011;127(1):145-152.
7. de Roos AJ, Cooper GS, Alavanja MC, Sandler DP. Personal and family medical history correlates of rheumatoid arthritis. Ann Epidemiol. 2008;18(6):433-439.
8. Kero J, Gissler M, Hemminki E, Isolauri E. Could TH1 and TH2 diseases coexist? evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study. J Allergy Clin Immunol. 2001;108(5):781-783.
9. Tirosh A, Mandel D, Mimouni FB, Zimlichman E, Shochat T, Kochba I. Autoimmune diseases in asthma. Ann Intern Med. 2006;144(12):877-883.
10. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology. 2005;129(3):827-836.
11. Fenta YA, Tello N, Jung JA, et al. Inflammatory bowel disease and asthma: a population-based, case-control study. Inflamm Bowel Dis. 16(11):1957-1962.
12. Weng X, Liu L, Barcellos LF, Allison JE, Herrinton LJ. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern California-managed care organization. Am J Gastroenterol. 2007;102(7):1429-1435.
13. EURODIAB Substudy 2 Study Group. Decreased prevalence of atopic diseases in children with diabetes. J Pediatr. 2000; 137(4):470-474.
14. Prosser R, Carleton B, Smith A. The comorbidity burden of the treated asthma patient population in British Columbia. Chronic Dis Can. 2010;30(2):46-55.
15. Adams RJ, Wilson DH, Taylor AW, et al. Coexistent chronic conditions and asthma quality of life: a population-based study. Chest. 2006;129(2):285-291.
16. Zhang T, Carleton BC, Prosser RJ, Smith AM. The added burden of comorbidity in patients with asthma. J Asthma. 2009;46(10):1021-1026.
17. van Den Broek J, Bachmann M, Kohler G, et al. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccine in a virus infection with a limited role of IFN- and nitric oxide synthetase 2. J Immunol. 2000;164(1):371-378.
18. Romagnani S. The Th1/Th2 paradigm. Immunol Today. 1997; 18(6):263-266.
19. US Census Bureau. 1980 and 1990 Census of Population and Housing. Washington, DC: US Census Bureau; 1983 and 1993.
20. Katusic SK, Colligan RC, Barbaresi WJ, Schaid DJ, Jacobsen SJ. Potential influence of migration bias in birth cohort studies. Mayo Clin Proc. 1998;73(11):1053-1061.
21. Yunginger JW, Reed CE, O'Connell EJ, Melton LJ III, O'Fallon WM, Silverstein MD. A community-based study of the epidemiology of asthma: incidence rates, 1964-1983. Am Rev Respir Dis. 1992;146(4):888-894.
22. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am. 1981;245(4):54-63.
23. Melton L. History of the Rochester Epidemiology Project. Mayo Clinic Proc. 1996;71:266-274.
24. Broder I, Higgins MW, Mathews KP, Keller JB. Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan, IV: natural history. J Allergy Clin Immunol. 1974;54(2):100-110.
25. Juhn YJ, Kita H, Yawn BP, et al. Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol. 2008;122(4):719-723.
26. Stonnington CM, Phillips SF, Melton LJ III, Zinsmeister AR. Chronic ulcerative colitis: incidence and prevalence in a community. Gut. 1987;28(4):402-409.
27. Gollop JH, Phillips SF, Melton LJ III, Zinsmeister AR. Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut. 1988;29(1):49-56.
28. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology. 1998;114(6):1161-1168.
29. Loftus CG, Loftus EV Jr, Harmsen WS, et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis. 2007;13(3):254-261.
30. Loftus EV Jr, Silverstein M, Sandborn W, Tremaine W, Harmsen W, Zinsmeister A. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut. 2000;46(3):336-343.
31. Leibson C, Milton LJ III, Palumbo PJ. Temporal trends in diabetes incidence and prevalence. Diabetes Care. 1997;20(3):460-462.
32. Dinneen SF, Maldonado D III, Leibson CL, et al. Effects of changing diagnostic criteria on the risk of developing diabetes. Diabetes Care. 1998;21(9):1408-1413.
33. Burke JP, O'Brien P, Ransom J, et al. Impact of case ascertainment on recent trends in diabetes incidence in Rochester, Minnesota. Am J Epidemiol. 2002;155(9):859-865.
34. Thomas RJ, Palumbo PJ, Melton LJ III, et al. Trends in the mortality burden associated with diabetes mellitus: a population- based study in Rochester, Minn, 1970-1994. Arch Intern Med. 2003;163(4):445-451.
35. Goraya TY, Jacobsen SJ, Kottke TE, Frye RL, Weston SA, Roger VL. Coronary heart disease death and sudden cardiac death: a 20-year population-based study. Am J Epidemiol. 2003; 157(9):763-770.
36. Elveback LR, Connolly DC, Kurland LT. Coronary heart disease in residents of Rochester, Minnesota, II: mortality, incidence, and survivorship, 1950-1975. Mayo Clin Proc. 1981; 56(11):665-672.
37. Roger VL, Jacobsen SJ, Weston SA, Bailey KR, Kottke TE, Frye RL. Trends in heart disease deaths in Olmsted County, Minnesota, 1979-1994. Mayo Clin Proc. 1999;74(7):651-657.
38. Doran MF, Pond GR, Crowson CS, O'Fallon WM, Gabriel SE. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum. 2002;46(3):625-631.
39. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315-324.
40. Gabriel SE, Crowson CS, O'Fallon WM. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum. 1999;42(3):415-420.
41. Juhn YJ, Johnson SK, Hashikawa AH, et al. The potential biases in studying the relationship between asthma and microbial infection. J Asthma. 2007;44(10):827-832.
42. Frey D, Jacobson R, Poland G, Li X, Juhn Y. Assessment of the association between pediatric asthma and Streptococcus pyogenes upper respiratory infection. Allergy Asthma Proc. 2009; 30(5):540-545.
43. Lynch BA, Fenta Y, Jacobson R, Li X, Juhn YJ. Impact of delay in asthma diagnosis on chest x-ray and antibiotic utilization by clinicians. J Asthma. 2012;49(1):23-28.
44. Lynch BA, Van Norman CA, Jacobson RA, Weaver AL, Juhn YJ. Impact of delay in asthma diagnosis on health care service utilization. Allergy Asthma Proc. 2010;31(4):48-52.
45. Wong CK, Ho CY, Ko FW, et al. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol. 2001;125(2):177-183.
46. Wu TL, Chang PY, Tsao KC, Sun CF, Wu LL, Wu JT. A panel of multiple markers associated with chronic systemic inflammation and the risk of atherogenesis is detectable in asthma and chronic obstructive pulmonary disease. J Clin Lab Anal. 2007;21(6):367-371.
47. Zhao Y, Yang J, Gao YD, Guo W. Th17 immunity in patients with allergic asthma. Int Arch Allergy Immunol. 2010;151(4):297-307.
48. Patterson CC, Smith AE, Yarnell JW, Rumley A, Ben-Shlomo Y, Lowe GD. The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: the Caerphilly Study. Atherosclerosis. 2010;209(2):551-557.
49. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3):327-334.